GENELUX Corp (GNLX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $133 million, GENELUX Corp is a micro-cap company. The stock currently trades at $2.90, down 2.52% today, with a 52-week range of $1.99–$8.54.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.95 | $-0.95 | +18.1% | |
| 2023 | $-1.16 | $-1.16 | — |